Clarity Financial LLC Has $774,000 Position in UnitedHealth Group Incorporated (NYSE:UNH)

Clarity Financial LLC decreased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 22.1% during the 4th quarter, Holdings Channel reports. The institutional investor owned 1,530 shares of the healthcare conglomerate’s stock after selling 433 shares during the period. Clarity Financial LLC’s holdings in UnitedHealth Group were worth $774,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. Kathleen S. Wright Associates Inc. purchased a new stake in UnitedHealth Group during the third quarter worth about $27,000. Global Wealth Strategies & Associates grew its stake in shares of UnitedHealth Group by 152.4% during the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after acquiring an additional 32 shares during the period. West Financial Advisors LLC purchased a new stake in UnitedHealth Group during the third quarter valued at about $32,000. AlphaMark Advisors LLC purchased a new stake in shares of UnitedHealth Group during the 4th quarter valued at approximately $30,000. Finally, RPg Family Wealth Advisory LLC bought a new position in shares of UnitedHealth Group in the third quarter worth $37,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the firm’s stock in a transaction that occurred on Friday, January 17th. The stock was bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now directly owns 4,500 shares in the company, valued at $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.33% of the company’s stock.

Analysts Set New Price Targets

UNH has been the topic of a number of analyst reports. TD Cowen upped their target price on shares of UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a report on Friday, October 18th. UBS Group decreased their target price on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday, October 16th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $700.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. Stephens lifted their price objective on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a report on Thursday, December 5th. Finally, Morgan Stanley reduced their price objective on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 16th. One equities research analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Buy” and a consensus price target of $629.32.

UnitedHealth Group Stock Up 1.3 %

NYSE UNH opened at $545.29 on Friday. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The business’s 50-day moving average is $538.18 and its 200 day moving average is $565.09. The stock has a market capitalization of $501.82 billion, a PE ratio of 35.18, a PEG ratio of 1.46 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. During the same quarter last year, the firm posted $5.83 earnings per share. The firm’s revenue was up 6.8% on a year-over-year basis. Sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.64 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were given a dividend of $2.10 per share. The ex-dividend date was Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.54%. UnitedHealth Group’s payout ratio is 54.19%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.